Stem Cell Research (Apr 2020)

Establishment of induced pluripotent stem cell line CSUASOi003- A from an autosomal recessive retinitis pigmentosa patient carrying compound heterozygous mutations in CRB1 gene

  • Yalan Zhou,
  • Chengcheng Ding,
  • Shutao Xia,
  • Yutong Jing,
  • Shengru Mao,
  • Jian Liu,
  • Juan Chen,
  • Hon fai Chan,
  • Shibo Tang,
  • Jiansu Chen

Journal volume & issue
Vol. 44

Abstract

Read online

Abstract:: Crumbs homologue 1 (CRB1) mutations have been found in retinitis pigmentosa (RP) patients lead to severe retinal dystrophies. The human induced pluripotent stem (iPS) cell line CSUASOi003-A derived from peripheral blood mononuclear cells (PBMCs) of a patient carrying two heterozygous mutations (2249G>A p.G750D and c.2809G>A p.A937T) in CRB1 gene was generated by non-integrative reprogramming technology. Pluripotency and differentiation capacity were assessed by immunocytochemistry and quantitative polymerase chain reaction (qPCR). The RP patient-specific iPS cell line provide a powerful model for evaluating the pathological phenotypes of the disease.